Supurva Healthcare Group, Inc.
SPRV · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $79 | $134 | $124 | $132 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $79 | $134 | $124 | $132 |
| Operating Income | -$79 | -$134 | -$124 | $884 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$54 | -$54 | -$45 | -$46 |
| Pre-Tax Income | -$133 | -$188 | -$170 | -$178 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$133 | -$188 | -$170 | -$178 |
| % Margin | – | – | – | – |
| EPS | 0 | -0 | -0 | -0 |
| % Growth | 100% | 0% | 0% | – |
| EPS Diluted | 0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 3,291,496 | 3,291,496 | 3,136,251 | 2,718,479 |
| Weighted Avg Shares Out Dil | 3,291,496 | 3,291,496 | 3,136,251 | 2,718,479 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $54 | $54 | $45 | $46 |
| Depreciation & Amortization | $0 | $0 | $43 | $44 |
| EBITDA | -$79 | -$134 | -$81 | $884 |
| % Margin | – | – | – | – |